Literature DB >> 16212883

Antigen processing by autoreactive B cells promotes determinant spreading.

Yang D Dai1, George Carayanniotis, Eli Sercarz.   

Abstract

Acute primary immune responses tend to focus on few immunodominant determinants using a very limited number of T cell clones for expansion, whereas chronic inflammatory responses generally recruit a large number of different T cell clones to attack a broader range of determinants of the invading pathogens or the inflamed tissues. In T cell-mediated organ-specific autoimmune disease, a transition from the acute to the chronic phase contributes to pathogenesis, and the broadening process is called determinant spreading. The cellular components catalyzing the spreading reaction are not identified. It has been suggested that autoreactive B cells may play a central role in diversifying autoreactive T cell responses, possibly through affecting antigen processing and presentation. The clonal identity and diversity of the B cells and antibodies seem critical in regulating T cell activity and subsequent tissue damage or repair. Here, we use two autoimmune animal models, experimental autoimmune thyroiditis (EAT) and type 1 diabetes (T1D), to discuss how autoreactive B cells or antibodies alter the processing and presentation of autoantigens to regulate specific T cell response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212883

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  23 in total

1.  Increased proteolysis of diphtheria toxin by human monocytes after heat shock: a subsidiary role for heat-shock protein 70 in antigen processing.

Authors:  Barbara S Polla; Françoise Gabert; Brigitte M-N Peyrusse; Muriel R Jacquier-Sarlin
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

Review 2.  B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage.

Authors:  Angela Lee Foreman; Judy Van de Water; Marie-Lise Gougeon; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2007-01-12       Impact factor: 9.754

Review 3.  Autoimmune Responses to Exosomes and Candidate Antigens Contribute to Type 1 Diabetes in Non-Obese Diabetic Mice.

Authors:  Yang D Dai; Huiming Sheng; Peter Dias; M Jubayer Rahman; Roman Bashratyan; Danielle Regn; Kristi Marquardt
Journal:  Curr Diab Rep       Date:  2017-10-28       Impact factor: 4.810

Review 4.  Narrowing in on the anti-β cell-specific T cells: looking 'where the action is'.

Authors:  Sally C Kent; Jenny Aurielle B Babon
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-04       Impact factor: 3.243

Review 5.  Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.

Authors:  Cheng-Rui Li; Bas J G Baaten; Linda M Bradley
Journal:  J Mol Cell Biol       Date:  2011-11-24       Impact factor: 6.216

6.  Autoantigens plus interleukin-10 suppress diabetes autoimmunity.

Authors:  Béla Dénes; István Fodor; William H R Langridge
Journal:  Diabetes Technol Ther       Date:  2010-08       Impact factor: 6.118

7.  Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.

Authors:  Woelsung Yi; Nilufer P Seth; Tom Martillotti; Kai W Wucherpfennig; Derek B Sant'Angelo; Lisa K Denzin
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

Review 8.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

9.  Recapitulation of posttransfusion purpura by cross-strain platelet immunization in mice.

Authors:  Daniel W Bougie; Jessica Sutton; Richard H Aster
Journal:  Blood Adv       Date:  2020-01-28

10.  Pathophysiological lessons from rare associations of immunological disorders.

Authors:  Pierre Ronco; Hanna Debiec
Journal:  Pediatr Nephrol       Date:  2008-10-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.